Prevention of Enteric Diseases

作者: Ina Stephens , James P. Nataro

DOI: 10.1007/978-1-4419-8993-2_11

关键词:

摘要: Estimates of diarrheal disease mortality suggest that at least 2 million persons succumb annually to diarrhea, and in countless others, the infections aggravate malnutrition its attendant ills. Though enteric diseases are nearly always spread by fecal-oral route, prevention illness improvement water food quality is impractical most developing countries. Yet, diversity pathogens presents a formidable obstacle more specific means, such as vaccination. We would argue, however, for certain infections, immunization both feasible efficient means prevention. Calculations burden can assist identifying problems which interventions should be pursued. review four vaccine development strategies have received wide attention. However, none these cases cheap effective yet available.

参考文章(102)
A.-M. Svennerholm, N. Lycke, J. Holmgren, C. Czerkinsky, Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant. American Journal of Tropical Medicine and Hygiene. ,vol. 50, pp. 42- 54 ,(1994)
C. V. Plowe, G. A. Losonsky, S. S. Wasserman, M. M. Levine, K. L. Kotloff, B. Koumaré, R. T. Perry, F. Bougoudogo, A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali. Bulletin of The World Health Organization. ,vol. 76, pp. 63- 71 ,(1998)
David M. Mel, Miroslav L. Radovanić, Božidar D. Nikolić, Bogoljub L. Arsić, Studies on vaccination against bacillary dysentery. 4. Oral immunization with live monotypic and combined vaccines. Bulletin of The World Health Organization. ,vol. 39, pp. 375- 380 ,(1968)
Tatsuo Yamamoto, Current Status of Cholera and Rise of Novel Mucosal Vaccine Japanese Journal of Infectious Diseases. ,vol. 53, pp. 181- 188 ,(2000)
Jie Yu, William H.R. Langridge, A plant-based multicomponent vaccine protects mice from enteric diseases Nature Biotechnology. ,vol. 19, pp. 548- 552 ,(2001) , 10.1038/89297
David Mel, Eugene J. Gangarosa, Stevan Litvinjenko, Miroslav L. Radovanović, Bogoljub L. Arsić, Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains. Bulletin of The World Health Organization. ,vol. 45, pp. 457- 464 ,(1971)
S J Cryz, M M Levine, G Losonsky, J B Kaper, B Althaus, Safety and immunogenicity of a booster dose of Vibrio cholerae CVD 103-HgR live oral cholera vaccine in Swiss adults. Infection and Immunity. ,vol. 60, pp. 3916- 3917 ,(1992) , 10.1128/IAI.60.9.3916-3917.1992
K L Kotloff, D A Herrington, T L Hale, J W Newland, L Van De Verg, J P Cogan, P J Snoy, J C Sadoff, S B Formal, M M Levine, Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen Infection and Immunity. ,vol. 60, pp. 2218- 2224 ,(1992) , 10.1128/IAI.60.6.2218-2224.1992
G Losonsky, O Castro, J Gutierrez, R Meza, J P Nataro, J B Kaper, S S Wasserman, R Edelman, M M Levine, S J Cryz, D N Taylor, C O Tacket, Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and Peru. Infection and Immunity. ,vol. 65, pp. 3852- 3856 ,(1997) , 10.1128/IAI.65.9.3852-3856.1997